Literature DB >> 15580365

Prevalence and clinical characteristics of tuberculosis in rheumatoid arthritis patients.

Fadoua Allali, Hanane Rkain, Afaf Faik, Selma El Hassani, Najia Hajjaj-Hassouni.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15580365     DOI: 10.1007/s10067-004-1037-x

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


× No keyword cloud information.
  11 in total

1.  The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis.

Authors:  F C Arnett; S M Edworthy; D A Bloch; D J McShane; J F Fries; N S Cooper; L A Healey; S R Kaplan; M H Liang; H S Luthra
Journal:  Arthritis Rheum       Date:  1988-03

2.  Fatal sepsis in a patient with rheumatoid arthritis treated with etanercept.

Authors:  M Baghai; D R Osmon; D M Wolk; L E Wold; G J Haidukewych; E L Matteson
Journal:  Mayo Clin Proc       Date:  2001-06       Impact factor: 7.616

3.  Mycobacterium tuberculosis infection in a corticosteroid-treated rheumatic disease patient population.

Authors:  H A Kim; C D Yoo; H J Baek; E B Lee; C Ahn; J S Han; S Kim; J S Lee; K W Choe; Y W Song
Journal:  Clin Exp Rheumatol       Date:  1998 Jan-Feb       Impact factor: 4.473

4.  Detection of Mycobacterium tuberculosis group organisms in human and mouse joint tissue by reverse transcriptase PCR: prevalence in diseased synovial tissue suggests lack of specific association with rheumatoid arthritis.

Authors:  K E Kempsell; C J Cox; A A McColm; J A Bagshaw; R Reece; D J Veale; P Emery; J D Isaacs; J S Gaston; J S Crowe
Journal:  Infect Immun       Date:  2001-03       Impact factor: 3.441

Review 5.  Anti-tumour necrosis factor agents and tuberculosis risk: mechanisms of action and clinical management.

Authors:  Michael A Gardam; Edward C Keystone; Richard Menzies; Steven Manners; Emil Skamene; Richard Long; Donald C Vinh
Journal:  Lancet Infect Dis       Date:  2003-03       Impact factor: 25.071

6.  Frequency of infections among rheumatoid arthritis patients, before and after disease onset.

Authors:  J P Vandenbroucke; R Kaaks; H A Valkenburg; J W Boersma; A Cats; J J Festen; A P Hartman; O Huber-Bruning; J J Rasker; J Weber
Journal:  Arthritis Rheum       Date:  1987-07

7.  Increased risk of tuberculosis in patients with rheumatoid arthritis.

Authors:  Loreto Carmona; César Hernández-García; Cristina Vadillo; Esperanza Pato; Alejandro Balsa; Isidoro González-Alvaro; Miguel Angel Belmonte; Xavier Tena; Raimon Sanmartí
Journal:  J Rheumatol       Date:  2003-07       Impact factor: 4.666

8.  Absence of Mycobacterium tuberculosis DNA in synovial fluid from patients with rheumatoid arthritis.

Authors:  H Jalal; M Millar; C Linton; P Dieppe
Journal:  Ann Rheum Dis       Date:  1994-10       Impact factor: 19.103

9.  The incidence and clinical characteristics of Mycobacterium tuberculosis infection among systemic lupus erythematosus and rheumatoid arthritis patients in Korea.

Authors:  J E Yun; S W Lee; T H Kim; J B Jun; S Jung; S C Bae; T Y Kim; D H Yoo
Journal:  Clin Exp Rheumatol       Date:  2002 Mar-Apr       Impact factor: 4.473

10.  Frequency of infection among patients with rheumatoid arthritis versus patients with osteoarthritis or soft tissue rheumatism.

Authors:  G A van Albada-Kuipers; J Linthorst; E A Peeters; F C Breedveld; B A Dijkmans; J Hermans; J P Vandenbroucke; A Cats
Journal:  Arthritis Rheum       Date:  1988-05
View more
  3 in total

Review 1.  Safety of tumor necrosis factor inhibitors use for rheumatoid arthritis and ankylosing spondylitis in Africa, the Middle East, and Asia: focus on severe infections and tuberculosis.

Authors:  Mohammed Hammoudeh; Abdurhman Alarfaj; Der-Yuan Chen; Hachemi Djoudi; Ehab Youseif; Jian Zhu
Journal:  Clin Rheumatol       Date:  2012-12-15       Impact factor: 2.980

2.  Choice of Biologic Therapy for Patients with Rheumatoid Arthritis: The Infection Perspective.

Authors:  Filip De Keyser
Journal:  Curr Rheumatol Rev       Date:  2011-02

Review 3.  Reactivation of latent tuberculosis with TNF inhibitors: critical role of the beta 2 chain of the IL-12 receptor.

Authors:  Marie Robert; Pierre Miossec
Journal:  Cell Mol Immunol       Date:  2021-05-21       Impact factor: 22.096

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.